67
Participants
Start Date
February 29, 2004
Primary Completion Date
February 28, 2006
Study Completion Date
February 28, 2006
Interferon Beta-1a
Institute of Clinical Neurosciences, Sydney
Liverpool Hospital, Liverpool
Royal Melbourne Hospital, Parkville
St. Vincent's Hospital, Fitzroy
Weill Medical College of Cornell University, New York
Raleigh Neurology Associates, Raleigh
University of Florida, Jacksonville, Jacksonville
University of Miami, Miami
University of Minnesota, Minneapolis
University of Kansas, Kansas City
Louisiana State University, New Orleans
University of Utah, Salt Lake City
Phoenix Neurological Associates, Ltd., Phoenix
Neuromuscular Research Center, Scottsdale
Harvard University/MGH, Boston
Tufts University/ St. Elizabeths, Boston
University of Texas Southwestern, Dallas
London Health Sciences Center, London
Montreal Neurological Hospital, Montreal
Guy's Hospital/Dept. of Neuroimmunology, London
Lead Sponsor
Biogen
INDUSTRY